AI in life sciences

Five bold predictions shaping R&D and compliance in 2026

AI will accelerate discovery, streamline development, and transform compliance in the year ahead. In this session, you’ll hear predictions on:

The innovations poised to reshape early R&D and preclinical science.
How emerging AI systems could change clinical trial design and execution.
The new governance standards that will unify analytics and ensure trust in AI across the enterprise.

Featured speakers

Chris McSpiritt

VP, Life Sciences Strategy

Chris McSpiritt is a Product Strategist and Business Architect with two decades of experience in life sciences technology. He began his career at an eClinical startup and has since held roles spanning project management, consulting, and product leadership. Today, Chris helps organizations align strategy with execution by shaping technology roadmaps, go-to-market plans, and AI-enabled solutions. He bridges customer needs with product innovation, guiding teams to modernize clinical research and achieve measurable impact. Passionate about the future of eClinical and AI, Chris brings clarity, creativity, and practical results to every engagement.

James O'Keefe

Head, Development and Regulatory Data, Digital & Technology

James O’Keefe is a seasoned life sciences and IT leader at Takeda , recognized for his customer-first approach and ability to lead complex initiatives with clarity and care. With deep expertise across regulatory operations, clinical operations, and process optimization, he has successfully driven large-scale transformation and growth, including P&L ownership of a $20M business and sustained 35% year-over-year revenue growth. Known for building high-performing, outcome-driven teams, James brings a consultancy mindset and strong business acumen to advancing operational excellence and innovation across the life sciences ecosystem.